- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|LLY-507 is a potent inhibitor of SMYD2 protein lysine methyltransferase activity, developed in a collaboration between the Structural Genomics Consortium (SGC) and Eli Lilly and Company .
Click here to link to the SGC's full list of epigenetics probes.
|GtoPdb PubChem SID||249565919|
|RCSB PDB Ligand||3UJ|
|Search Google for chemical match using the InChIKey||PNYRDVBFYVDJJI-UHFFFAOYSA-N|
|Search Google for chemicals with the same backbone||PNYRDVBFYVDJJI|
|Search UniChem for chemical match using the InChIKey||PNYRDVBFYVDJJI-UHFFFAOYSA-N|
|Search UniChem for chemicals with the same backbone||PNYRDVBFYVDJJI|
|SynPHARM||81854 (in complex with SET and MYND domain containing 2)|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Cat. No. 5365